IMMUNOHISTOCHEMISTRY, CD 3

The Immunohistochemistry (IHC) – CD3 test is a specialized diagnostic test used to detect CD3 protein expression in tissue samples. CD3 is a key surface protein found on T-lymphocytes (T-cells) and plays an essential role in immune system signaling and T-cell activation.

This test is widely used in hematopathology to identify T-cells and diagnose T-cell lymphomas and other lymphoid disorders. Detecting CD3 expression helps pathologists determine whether abnormal lymphoid cells are of T-cell origin, which is critical for accurate diagnosis and treatment planning.

The CD3 marker is especially useful in diagnosing:

• T-cell lymphomas
• Peripheral T-cell neoplasms
• T-lymphoblastic lymphoma
• Reactive lymphoid proliferations
• Differentiation of T-cell and B-cell lymphoid disorders

The CD3 test helps distinguish T-cell lymphomas from B-cell lymphomas, which require different treatment strategies and have different clinical outcomes.

The CD3 IHC test is often performed alongside markers such as CD20, CD5, CD4, CD8, CD30, and Ki-67 for complete immune-cell profiling and accurate tissue classification.

Benefits of the Test

The CD3 test offers several important clinical benefits:

• Detects T-cell marker expression accurately
• Helps diagnose T-cell lymphomas
• Supports immune-cell classification
• Assists in differentiating lymphoid neoplasms
• Improves diagnostic precision
• Helps guide treatment planning

This test is essential for accurate lymphoid tissue diagnosis.

Why Doctors Recommend This Test

Doctors recommend the CD3 test when T-cell-related disease is suspected.

It is commonly advised for:

• Suspected T-cell lymphoma diagnosis
• Lymph node biopsy evaluation
• Immune-cell lineage classification
• Differentiation of T-cell and B-cell disorders
• Advanced hematopathology confirmation cases

The results help hematologists and oncologists establish accurate diagnosis and treatment strategies.

Preparation Before Test

No special preparation is required from the patient. The test is performed on previously collected lymph node biopsy or tissue specimens.

Normal Reporting Time

The usual turnaround time for the CD3 IHC test is 2 to 5 working days, depending on tissue complexity and laboratory workflow.

Who Should Take This Test

This test is recommended for:

• Patients with enlarged lymph nodes
• Individuals suspected of T-cell lymphoma
• Patients requiring immune-cell classification
• Cases needing lymphoid tissue diagnosis
• Oncology patients requiring precise pathology confirmation

The IHC CD3 test is an essential diagnostic tool in hematopathology. It accurately identifies T-cell lineage, improves diagnostic confidence, and supports personalized treatment planning for better patient outcomes.